Amarin Corp Plc (AMRN)

[Whalatane]

So your best offer is to allow Hikma / Dr Reddy only 1 yr ahead of the current Aug 2029 agreed on with Apotex / Teva ?
I don't see them accepting that if they feel they have anything close to a 50% chance of winning the appeal.

Look at it from Hikma / Dr R side. They know AMRN will cut marketing spend at a certain pt ...to maximize profit before the generics enter. . AMRN may spend $70m a yr on marketing , sales reps etc for the first 2 yrs until they feel the return on that spend is declining .....and then slash those expenses at whatever level sales are .

Kiwi